UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Selective Thyroid Hormone Receptor-β Activation: A Strategy for Reduction of Weight, Cholesterol, and Lipoprotein (a) with Reduced Cardiovascular Liability

Proceedings of the National Academy of Sciences - PNAS, 2003-08, Vol.100 (17), p.10067-10072

2003

Volltextzugriff (PDF)

Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors

Circulation (New York, N.Y.), 1992-10, Vol.86 (4), p.1310-1316

1992

Volltextzugriff (PDF)

Specific Block of the Anti-Ischemic Actions of Cromakalim by Sodium 5-Hydroxydecanoate

Circulation research, 1991-10, Vol.69 (4), p.949-958

1991

Volltextzugriff (PDF)

Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide

The Journal of pharmacology and experimental therapeutics, 1989-10, Vol.251 (1), p.98

1989

Volltextzugriff (PDF)

The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts

The Journal of pharmacology and experimental therapeutics, 1993-05, Vol.265 (2), p.559

1993

Volltextzugriff (PDF)

Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts

The Journal of pharmacology and experimental therapeutics, 1992-12, Vol.263 (3), p.1074

1992

Volltextzugriff (PDF)

Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides

The Journal of pharmacology and experimental therapeutics, 1991-04, Vol.257 (1), p.156

1991

Volltextzugriff (PDF)

Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection

The Journal of pharmacology and experimental therapeutics, 1991-06, Vol.257 (3), p.919

1991

Volltextzugriff (PDF)

Binding of ATP-Sensitive Potassium Channel (KATP) Openers to Cardiac Membranes: Correlation of Binding Affinities with Cardioprotective and Smooth Muscle Relaxing Potencies

Journal of medicinal chemistry, 1998-01, Vol.41 (3), p.271-275

1998

Volltextzugriff (PDF)

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KA TP) Openers. 6. Effect of Modifications at C6 of Benzopyranyl Cyanoguanidines

Journal of medicinal chemistry, 1999-09, Vol.42 (18), p.3711-3717

1999

Volltextzugriff (PDF)

Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia

Cardiovascular research, 1994-06, Vol.28 (6), p.881-887

1994

Volltextzugriff (PDF)

Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel

The Journal of pharmacology and experimental therapeutics, 1993-05, Vol.265 (2), p.609

1993

Volltextzugriff (PDF)

Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents

The Journal of pharmacology and experimental therapeutics, 1991-10, Vol.259 (1), p.97

1991

Volltextzugriff (PDF)

Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891

European journal of pharmacology, 1990-11, Vol.191 (1), p.11-18

1990

Volltextzugriff (PDF)

The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism

The Journal of pharmacology and experimental therapeutics, 1994-05, Vol.269 (2), p.536

1994

Volltextzugriff (PDF)

The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation

The Journal of pharmacology and experimental therapeutics, 1994-01, Vol.268 (1), p.90

1994

Volltextzugriff (PDF)

In vitro effects of capsaicin: antiarrhythmic and antiischemic activity

European journal of pharmacology, 1995-01, Vol.272 (2), p.269-278

1995

Volltextzugriff (PDF)

Ruthenium Red Improves Postischemic Contractile Function in Isolated Rat Hearts

Journal of cardiovascular pharmacology, 1990-11, Vol.16 (5), p.783-789

1990

Volltextzugriff (PDF)

Dissociation of Cardiodepression from Cardioprotection with Calcium Antagonists: Diltiazem Protects Ischemic Rat Myocardium with a Lower Functional Cost as Compared with Verapamil or Nifedipine

Journal of cardiovascular pharmacology, 1989-08, Vol.14 (2), p.331-340

1989

Volltextzugriff (PDF)

Cardioprotective Effects of the Cyanoguanidine Potassium Channel Opener P-1075

Journal of cardiovascular pharmacology, 1993-10, Vol.22 (4), p.564-576

1993

Volltextzugriff (PDF)

Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim

The Journal of pharmacology and experimental therapeutics, 1993-10, Vol.267 (1), p.102

1993

Volltextzugriff (PDF)

Glyburide-Reversible Cardioprotective Effects of BMS-180448: Functional and Energetic Considerations

Journal of cardiovascular pharmacology, 1997-01, Vol.29 (1), p.28-38

1997

Volltextzugriff (PDF)

Cardioselective anti-ischemic ATP-sensitive potassium channel openers

Journal of medicinal chemistry, 1993-11, Vol.36 (24), p.3971-3974

1993

Volltextzugriff (PDF)

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KATP) Openers. 5. Identification of 4-(N-Aryl)-Substituted Benzopyran Derivatives with High Selectivity

Journal of medicinal chemistry, 1997-01, Vol.40 (1), p.24-34

1997

Volltextzugriff (PDF)

A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog

European journal of pharmacology, 1995-12, Vol.294 (1), p.271-280

1995

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(82)

Sprache

Englisch
(81)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Animals
(59)
Rats
(50)
Biological And Medical Sciences
(48)
Male
(48)
Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Medical Sciences
(44)
Pharmacology. Drug Treatments
(37)
Pharmacology & Pharmacy
(36)
Cardiovascular System
(31)
In Vitro Techniques
(30)
Rats, Sprague-Dawley
(26)
Heart - Drug Effects
(25)
Potassium Channels - Drug Effects
(24)
Benzopyrans - Pharmacology
(20)
Chemistry, Medicinal
(16)
Coronary Circulation - Drug Effects
(16)
Cromakalim
(16)
Dogs
(16)
Glyburide - Pharmacology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective Thyroid Hormone Receptor-β Activation: A Strategy for Reduction of Weight, Cholesterol, and Lipoprotein (a) with Reduced Cardiovascular Liability

Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors

Specific Block of the Anti-Ischemic Actions of Cromakalim by Sodium 5-Hydroxydecanoate

Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide

The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts

Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts

Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides

Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection

Binding of ATP-Sensitive Potassium Channel (KATP) Openers to Cardiac Membranes: Correlation of Binding Affinities with Cardioprotective and Smooth Muscle Relaxing Potencies

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KA TP) Openers. 6. Effect of Modifications at C6 of Benzopyranyl Cyanoguanidines

Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia

Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel

Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents

Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891

The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism

The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation

In vitro effects of capsaicin: antiarrhythmic and antiischemic activity

Ruthenium Red Improves Postischemic Contractile Function in Isolated Rat Hearts

Dissociation of Cardiodepression from Cardioprotection with Calcium Antagonists: Diltiazem Protects Ischemic Rat Myocardium with a Lower Functional Cost as Compared with Verapamil or Nifedipine

Cardioprotective Effects of the Cyanoguanidine Potassium Channel Opener P-1075

Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim

Glyburide-Reversible Cardioprotective Effects of BMS-180448: Functional and Energetic Considerations

Cardioselective anti-ischemic ATP-sensitive potassium channel openers

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KATP) Openers. 5. Identification of 4-(N-Aryl)-Substituted Benzopyran Derivatives with High Selectivity

A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog

Suchergebnisse filtern